JC
Jeremy G Chadwick
Chief Operating Officer

Jeremy G Chadwick insider trades: Kymera Therapeutics (KYMR) stock sales

Chief Operating Officer, Kymera Therapeutics Last trade May 27, 2026 16 Form 4 filings
$15.6M
Sold, last 12 months
6 sales
$0
Bought, last 12 months
0 buys
10
Open-market trades
since 2009
2
Companies
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Jeremy reports to the SEC

Open-market buys and sales

10 trades reported on SEC Form 4, newest first

DateStockTypeValue
May 27, 2026KYMR↓ Sell$1.4M
Apr 15, 2026KYMR↓ Sell$590K
Apr 1, 2026KYMR↓ Sell$1.9M
Mar 25, 2026KYMR↓ Sell$9.0M
Mar 11, 2026KYMR↓ Sell$2.1M
Mar 4, 2026KYMR↓ Sell$516K
May 23, 2025KYMR↓ Sell$75K
Mar 3, 2025KYMR↓ Sell$42K
May 23, 2024KYMR↓ Sell$90K
Jan 5, 2009SNTA↓ Sell$28K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other KYMR insiders

Open-market trades in the last 12 months

About Jeremy G Chadwick's insider trades

Jeremy G Chadwick is Chief Operating Officer at Kymera Therapeutics (KYMR). Since Jan 5, 2009, Jeremy has reported no open-market purchases and 10 sales worth $15.8M on SEC Form 4. In the last 12 months: 6 sales ($15.6M).

Their filings also include grants and awards (8 filings), option exercises (4 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every KYMR insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.